    Drasko Puseljic | Kidd Consultants LLC | ZoomInfo.com






Drasko Puseljic - Previous Director for Enhance Skin Products Inc










































 Drasko Puseljic
                        

Archived Record













Follow



 Share
                        





 PDF
                        

 Excel
                        
























Drasko Puseljic Overview
                    

Drasko Puseljic has been associated with one company, according to public records. The company was incorporated in Nevada ten years ago.
                    
                






Background Report for Drasko Puseljic


 Includes Age, Location, Address History for Drasko Puseljic
 Arrest, Criminal, & Driving Records 
 Social Media Profiles
 Possible relatives
 Full Background Report 




                    Get Report
                



                        Sponsored Advertisement

                    













 Excel
                    
Companies for Drasko Puseljic








Name
Status
Incorporated
Key People
Role






                            Enhance Skin Products Inc
                        



                        Inactive
                    


                        
                            2006
                        
                


                                1
                            



                                Director
                            
















Advertisements










Source







Nevada Secretary of State
                                Data last refreshed on Monday, February 20, 2017
                            









What next?






Follow


Receive an email notification when changes occur for Drasko Puseljic.
Notifications include:

New company roles
Change in active status
Location updates
New connections






Follow








Create Account


Create a free account to access additional details for Drasko Puseljic and other profiles that you visit
Benefits include:

Access to more records
Full screen network visualizer
Follow profiles
See how people are connected




 Create Account
                                














            Advertisements
        





















                Wiki
            


 Edit this profile
                




                Source
            





                        Nevada Secretary of State
                    







top






















You must be signed in to print.
Once signed in, look for the PDF button.















	
        Compensation Information for Drasko  Puseljic , GC of ENHANCE SKIN PRODUCTS INC | Salary.com
    


























Enterprise
Small Business
Personal




Contact Us
Log In


































Salaries
Jobs
Education
Advice
























 





Drasko  Puseljic 
Executive Compensation
As GC at ENHANCE SKIN PRODUCTS INC, Drasko  Puseljic  made $63,000 in total compensation.  Of this total $0 was received as a salary, $0 was received as a bonus, $0 was received in stock options, $0 was awarded as stock and $63,000 came from other types of compensation. This information is according to proxy statements filed for the 2016 fiscal year. 


ENTER AN EXECUTIVE OR COMPANY NAME
New Search


Go



The chart on this page features a breakdown of the total annual pay for Drasko  Puseljic ,  GC at ENHANCE SKIN PRODUCTS INC as reported in their proxy statements. 
Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. ENHANCE SKIN PRODUCTS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. ENHANCE SKIN PRODUCTS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.
Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.
Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.



Other Executives at this Company


Donald  Nicholson 
Samuel  Asculai 
Frode  Botnevik 







Drasko  Puseljic 


Base Pay$0
Bonus + Incentive Comp$0
Total Cash Compensation$0


Stock Award Value$0
Option Award Value$0
Total Equity$0



Total Other$63,000



Total Compensation$63,000




Browse Executives by First Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z


Browse Companies by Company Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#



This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement. 
Use of Data / Disclaimer
The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.
What is a proxy statement?
A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.
The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.







    





 

 






     

privacy policy
terms of use
about us
contact us

©  Salary.com. All rights reserved.


US Salaries
Canadian Salaries
Purchase a Salary Report
Salaries by Category
Salaries by Income
Salaries by Industry
Popular Salaries
Negotiation Tips
Benefits Calculator
Search Job Openings
Job Openings by State
Job Openings by Category
Education by Career
Education by Level
Education by Major
Cost of Living Calculator
























 



EHSK Insider Trading - Enhance Skin Products Inc - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Enhance Skin Products Inc (EHSK)





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-12-02Other
2016-12-0510:20 am
N/AN/A
Enhance Skin Products Inc
EHSK
Botnevik FrodeDirector
1,944,444
$0.0018
5,771,926(Direct)
View


2016-12-02Other
2016-12-0510:20 am
N/AN/A
Enhance Skin Products Inc
EHSK
Botnevik FrodeDirector
503,013
$0.0101
5,771,926(Direct)
View


2016-12-02Other
2016-12-0510:19 am
N/AN/A
Enhance Skin Products Inc
EHSK
Puseljic DraskoLegal Counsel10% Owner
10,654,920
$0.0037
40,380,524(Direct)
View


2016-12-02Other
2016-12-0510:19 am
N/AN/A
Enhance Skin Products Inc
EHSK
Puseljic DraskoLegal Counsel10% Owner
16,333,333
$0.0018
40,380,524(Direct)
View


2016-12-02Other
2016-12-0510:19 am
N/AN/A
Enhance Skin Products Inc
EHSK
Puseljic DraskoLegal Counsel10% Owner
4,225,606
$0.0101
40,380,524(Direct)
View


2016-12-02Other
2016-12-0510:18 am
N/AN/A
Enhance Skin Products Inc
EHSK
Asculai SamuelChief Scientific OfficerDirector10% Owner
16,333,333
$0.0018
52,978,044(Direct)
View


2016-12-02Other
2016-12-0510:18 am
N/AN/A
Enhance Skin Products Inc
EHSK
Asculai SamuelChief Scientific OfficerDirector10% Owner
4,225,606
$0.0101
52,978,044(Direct)
View


2016-12-02Other
2016-12-0510:17 am
N/AN/A
Enhance Skin Products Inc
EHSK
Nicholson DonaldPresident and CEODirector10% Owner
8,826,595
$0.0037
177,235,216(Indirect)
View


2016-12-02Other
2016-12-0510:17 am
N/AN/A
Enhance Skin Products Inc
EHSK
Nicholson DonaldPresident and CEODirector10% Owner
50,094,948
$0.0037
177,235,216(Indirect)
View


2016-12-02Other
2016-12-0510:17 am
N/AN/A
Enhance Skin Products Inc
EHSK
Nicholson DonaldPresident and CEODirector10% Owner
71,232,224
$0.0018
177,235,216(Indirect)
View


2016-12-02Other
2016-12-0510:17 am
N/AN/A
Enhance Skin Products Inc
EHSK
Nicholson DonaldPresident and CEODirector10% Owner
27,261,112
$0.0018
177,235,216(Indirect)
View


2016-12-02Other
2016-12-0510:17 am
N/AN/A
Enhance Skin Products Inc
EHSK
Nicholson DonaldPresident and CEODirector10% Owner
10,820,340
$0.0101
177,235,216(Indirect)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 06:07:16 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  











EHSK Drasko Puseljic Insider Trades for Enhance Skin Products Inc.


































Bulletin






Investor Alert







New York Markets Open in:



Market Snapshot
Analyst Ratings


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Enhance Skin Products Inc.

                  OTC: EHSK
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Enhance Skin Products Inc.



Market closed
 --Quotes are delayed by 20 min
Jul 7, 2017, 5:20 p.m.


EHSK

/quotes/zigman/4222340/delayed


$
0.0025




Change

0.00
0.00%

Volume
Volume 6,000
Quotes are delayed by 20 min








/quotes/zigman/4222340/delayed
Previous close

$
			0.0025
		


$
				0.0025
			
Change

0.00
0.00%





Day low
Day high
n/a
n/a


52 week low
52 week high

            $0.0020
        

            $0.03
        


















Insider Activity


Individual




Drasko Puseljic



Mr. Drasko Puseljic is General Counsel at Enhance Skin Products, Inc.
He received his undergraduate degree from McMaster University, a graduate degree from Osgoode Hall Law School, and an MBA from the University of Toronto.



Transactions


Date
Shares
Transaction
Value





12/02/2016
4,225,606


 



42,256


12/02/2016
16,333,333


 



0


12/02/2016
10,654,920


 



0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Dr. Samuel S. Asculai 
Chairman & Chief Scientific Officer




Mr. Donald  Nicholson 
President, Chief Executive Officer, CFO & Director




Mr. Drasko  Puseljic 
General Counsel




Mr. Frode  Botnevik 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




7:07 AM EDT
July 28, 2017


/marketstate/country/us
New York

	Pre


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
7:06aIntel stock price target raised to $39 from $38 at SunTrust RH
7:06aMasterCard stock price target raised to $145 from $135 at SunTrust RH
7:05aCharter Communications stock price target raised to $400 from $380 at SunTrust RH
7:04aWhy the GDP report may show U.S. economy growing twice as fast
7:00aHow to curb your social media addiction 
7:00aA Bright Picture for Netflix
7:00aHow to curb your social media addiction
7:00aEuropean stocks drop to 3-month low as UBS falls, tech worries weigh 
6:59aMerck profit and sales rise, beat expectations amid big jump in Keytruda sales
6:59aA.O. Smith’s bet on China’s air-pollution problem is paying off
6:58aExxon earnings: Will stock trade higher on expected second-quarter beat?
6:58aFoxconn’s history of broken promises casts a shadow on Wisconsin news
6:58aHigh Times is going public through a deal with a blank-check company — and here’s what that means
6:57aIntel earnings have message for AMD and Nvidia: ‘Bring it on’
6:56aAmazon’s free-spending ways hit earnings, but don’t expect a shift to thrift
6:51aMerck Q2 Januvia/Janumet revenue $1.51 bln vs. $1.63 bln; FactSet consensus $1.62 bln
6:50aMerck Q2 Keytruda sales $881 mln vs. $314 mln a year ago; FactSet consensus $787.5 mln
6:49aMerck raises 2017 revenue outlook to $39.4 bln-$40.4 bln from $39.1 bln-$40.3 bln
6:48aMerck affirms 2017 adj. EPS outlook of $3.76-$3.88
6:47aMerck Q2 revenue $9.93 bln vs. $9.84 bln; FactSet consensus $9.75 bln
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,796.55

+85.54
+0.39%





nasdaq

/quotes/zigman/12633936/realtime
6,382.19

-40.56
-0.63%





s&p 500

/quotes/zigman/3870025/realtime
2,475.42

-2.41
-0.10%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15
























































Presenting pure hydration for the skin | Visible Youth













Contact Us
Filings
Stock Quotes
News
About Us
Home


 




Company Overview
Meet the Team
             

What is Hyaluronic Acid?
Scientific Studies
Products
Legal Notices




MANAGEMENT
    				Donald Nicholson 
Samuel Asculai
Drasko Puseljic 
		                                       
BOARD OF DIRECTORS				
					Frode Botnevik 




Donald Nicholson
President & Chief Executive Officer and Director
Mr. Nicholson holds a BCom Law degree (with Honors) in Business and Law from the University of Edinburgh.  Mr. Nicholson is a member of the Institute of Chartered Accountants of Scotland has more than 27 years of experience in the healthcare industry. Mr. Nicholson is, currently, the founding shareholder, and Chief Executive Officer of Mercuriali Ltd., a development stage United Kingdom private healthcare company. Prior to that, Mr. Nicholson was the founding shareholder and Chief Financial Officer of Stravencon Ltd., a European developer and marketer of generic pharmaceutical products manufactured in China. Prior to that he was Chief Financial Officer of SkyePharma Plc a UK specialty pharmaceutical company listed on the London market and on the US Nasdaq market. He was also a Director of SkyePharma Plc. Mr. Nicholson held a number of positions with Wellcome plc and Corange Ltd, the holding company of Boehringer Mannheim and DePuy, where he was corporate strategy and finance director. Mr. Nicholson has extensive experience in product and company acquisitions and disposals, in and out-licensing arrangements, sale/royalty agreements and financial strategy and funding structures. His industry experience includes Pharmaceuticals, Biochemicals, Orthopaedics, Diagnostics and Drug Delivery including Dermatology. 



Sam Asculai
Chairman of Board and Chief Scientific Officer

Dr. Asculai, the holder of a Masters degree and a Ph.D. in Microbiology from Rutgers University, has more than 40 years of experience in the life science industry.  Dr. Asculai is the inventor on over 50 U.S. patents, including over 30 patents related to hyaluronic acid, the cornerstone of Enhance Skin Products Inc.’s product line.  Over the course of his career, Dr. Asculai has contributed to the development of products that have achieved cumulative sales of close to two billion dollars including, Monistat, Delfen Cream for herpes virus infectons, Ganciclovir, Solaraze, and MACI. 

Immediately prior to his current role, Dr. Asculai was the sole owner of a private company whose assets form the basis for Enhance Skin Products Inc.’s operations. For ten years, Dr. Asculai served as Chief Executive Officer of Hyal Pharmaceutical Corporation where he developed the technology underpinning the Visible Youth™ brand. There he also invented and developed Solaraze a topical treatment for actinic keratosis, a precancerous skin condition that is commonly referred to as sunspots.  

Dr. Asculai also held senior positions with Verigen AG, a tissue engineering company; ens Bio-Logicals ; Monsanto Corporation, a multinational agricultural biotechnology company; and the Ortho Pharmaceutical Corporation division of Johnson & Johnson, a multinational pharmaceutical company.


Drasko Puseljic 
General Counsel
Mr. Puseljic is the holder of a B.Sc., Honours in Biology from McMaster University, an LL.B. from Osgoode Hall Law School and an M.B.A from the University of Toronto. He has held legal and/or business development roles at Hyal Pharmaceutical Corporation, Visible Genetics Inc., Verigen AG and Enhance Skin Products Inc., a private company whose assets are the basis for the Company’s operations. He also has investment banking experience with Eureka Capital Markets, a boutique investment bank. Currently, in addition to his role with Enhance Skin Products, Mr. Puseljic is a senior consultant with Kidd Consultants LLC, a firm providing financial and strategic consulting services internationally to life sciences companies.


BOARD OF DIRECTORS
Frode Botnevik 
Director
Mr. Botnevik is a partner of Management & Finance AS, a Norwegian financial consulting firm that provides services in the areas of project and export financing, structured finance, risk management, financial restructuring, strategic partners and mergers and acquisitions. Mr. Botnevik has over 30 years of experience of industrial and financial experience and has been involved in the process of listing companies on the Oslo and Singapore stock exchanges and on Nasdaq. Mr. Botnevik has served on the boards of directors of companies in more than twelve countries.


Monistat, Delfen, Solaraze and MACI are trademarks of their respective owners  







Drasko Puseljic, Enhance Skin Products Inc: Profile & Biography - Bloomberg


































































  


























Feedback





Drasko Puseljic

General Counsel,
Enhance Skin Products Inc






Career History




General Counsel
Enhance Skin Products Inc, 3/2013-PRESENT



Hyal Pharmaceutical Corp, FORMER



Visible Genetics Inc, FORMER



Verigen AG, FORMER


Show More









Website:
www.enhanceskinproducts.com






Corporate Information
Address:

695 South Colorado Boulevard
Suite 480
Denver, CO 80246
United States


Phone:
1-800-817-7161


Fax:
-


Web url:
www.enhanceskinproducts.com











From The Web












Personal Information



Education



Degroote School of Business
Bachelor's Degree


Osgoode Hall Law School of York University
LLB


University of Toronto
MBA


Show More








Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data































     EHSK Company Profile & Executives - Enhance Skin Products Inc. - Wall Street Journal                                     DOW JONES, A NEWS CORP COMPANY         News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services.  DOW JONES  Barron's BigCharts DJX Dow Jones Newswires Factiva Financial News Mansion Global MarketWatch   Newsmart NewsPlus Private Markets Risk & Compliance WSJ.com WSJ Pro WSJ Conference WSJ Video    NEWS CORP  Big Decisions Business Spectator Checkout51 Harper Collins New York Post PropTiger REA   realtor.com Storyful The Australian The Sun The Times              DJIA Futures ▲  21709 -0.16%        S&P 500 F ▲  2463.50 -0.34%        Stoxx 600 ▲  378.17 -1.09%        U.S. 10 Yr ▲  -4/32 yield 2.326%        Crude Oil ▲  49.08 0.08%        Euro ▲  1.1709 0.28%                 Subscribe Now Sign In      The Wall Street Journal     U.S. Edition  U.S. Asia Europe India 中国 (China) 日本 (Japan)    July 28, 2017   Today's Paper     Sections    My Journal       Home   World   U.S.   Politics   Economy   Business   Tech   Markets   Opinion   Arts   Life   Real Estate   Today's Paper   SHOW ALL SECTIONS HIDE ALL SECTIONS     World Home   Africa Asia Canada China Europe Latin America Middle East   Economy   World Video     U.S. Home   Economy Law New York Politics   Real Time Economics Washington Wire   Journal Report U.S. Video What's News Podcast     Politics Home   Washington Wire   Politics Video WSJ/NBC News Poll     Economy Home   Real Time Economics   Economic Forecasting Survey Economy Video     Business Home   Management Tech/WSJ.D   Aerospace & Defense Autos & Transportation Commercial Real Estate Consumer Products Energy Entrepreneurship Financial Services Food & Services Health Care Hospitality Law Manufacturing Media & Marketing Natural Resources Retail   CFO Journal CIO Journal CMO Today Logistics Report Risk & Compliance   Heard on the Street   Business Video Journal Report Business Podcast     Tech Home   CIO Journal   Geoffrey Fowler Christopher Mims Joanna Stern Li Yuan   Billion Dollar Startup Club Tech Video Tech Podcast Startup Stock Trader     Markets Home   Bonds Commercial Real Estate Commodities & Futures Currencies Deals Financial Services Funds Stocks Your Money   Heard on the Street MoneyBeat Wealth Adviser Ahead of the Tape   CFO Journal Journal Report Market Data Markets Video Markets Podcast MoneyBeat Podcast Watching Your Wealth Podcast     Opinion Home   James Freeman William A. Galston Daniel Henninger Holman W. Jenkins William McGurn Peggy Noonan Mary Anastasia O'Grady Jason Riley Kimberley A. Strassel   Books Film Television Theater Art Masterpiece Series Music Dance Opera Exhibition Cultural Commentary   Editorials Commentary Letters to the Editor The Weekend Interview Potomac Watch Podcast Foreign Edition Podcast Opinion Video Notable & Quotable Best of the Web Newsletter Morning Editorial Report Newsletter     Arts Home   Books Film Television Theater Art Masterpiece Series   Arts Video WSJ. Magazine     Life Home   Careers Cars Food & Drink Health Ideas Real Estate Science Sports Style & Fashion Travel   Life Video WSJ. Magazine WSJ Puzzles The Future of Everything     Real Estate Home   Commercial Real Estate House of the Day Mansion   Real Estate Video      HIDE ALL SECTIONS      Aim higher, reach further.  Get the Wall Street Journal $12 for 12 weeks. Subscribe Now   Sign In   Reveal Navigation Options    Subscribe Sign In              Enhance Skin Products Inc. EHSK (U.S.: OTC)      search    View All companies           AT CLOSE 5:20 PM EDT 07/07/17     $0.0025 USD     0.00 0.00%     Volume 6,000       Volume 6,000     65 Day Avg Vol 60,255     1 Day Range 0.0025 - 0.0025     52 Week Range 0.002 - 0.025 (07/14/16 - 10/04/16)          1 D 5 D 1 M 3 M YTD 1 Y 3 Y    $ %            Advanced Charting Compare     Compare to Benchmark:   DJIA   S&P 500   GLOBAL DOW   NASDAQ   Consumer Goods      Compare to    Add          Open  0.0025   Prior Close  0.0025 (06/30/17)     1 Day    EHSK 0.00%     DJIA 0.39%     Russell 2K -0.60%     Consumer Goods 0.00%                             Overview Profile Key People     Overview Profile Financials Income Statement Balance Sheet Cash Flow Research & Ratings Historical Prices Options Advanced Charting              Drasko Puseljic, 47 General Counsel, Enhance Skin Products, Inc. Mr. Drasko Puseljic is General Counsel at Enhance Skin Products, Inc. He received his undergraduate degree from McMaster University, a graduate degree from Osgoode Hall Law School, and an MBA from the University of Toronto.          News Enhance Skin Products Inc.EHSK   Significant News Only       06/15/17 Press Release   Enhance Skin Products Inc. Files Form 15 to Terminate SEC Reporting Obligations   Press Release     load more                All Company Executives Enhance Skin Products Inc.       Samuel S. Asculai, 73 Chairman & Chief Scientific Officer     Donald Nicholson, 57 President, Chief Executive Officer, CFO & Director     Drasko Puseljic, 48 General Counsel     Frode Botnevik, 68 Independent Director      expand          Advertisement                 Notes & Data Providers   Real-time U.S. stock quotes reflect trades reported through Nasdaq only. International stock quotes are delayed as per exchange requirements. Indexes may be real-time or delayed; refer to time stamps on index quote pages for information on delay times. Quote data, except U.S. stocks, provided by SIX Financial Information. Data is provided "as is" for informational purposes only and is not intended for trading purposes. SIX Financial Information (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements.  All of the mutual fund and ETF information contained in this display was supplied by Lipper, A Thomson Reuters Company, subject to the following: Copyright  © Thomson Reuters. All rights reserved. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Bond quotes are updated in real-time. Source: Tullett Prebon. Currency quotes are updated in real-time. Source: Tullet Prebon. Fundamental company data and analyst estimates provided by FactSet. Copyright  FactSet Research Systems Inc. All rights reserved.        Advertisement                